Contact Us
Primary Care POC Diagnostics Global Market Report 2025
Global Primary Care POC Diagnostics Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Primary Care POC Diagnostics Global Market Report 2025

By Product (Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products), By Prescription (Prescription Based, Over-The-Counter (OTC) Testing), By End-Use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Primary Care POC Diagnostics Market Overview

• Primary Care POC Diagnostics market size has reached to $16.35 billion in 2024

• Expected to grow to $22.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%

• Growth Driver: Driving Forces Behind The Growth Of Primary Care Point-Of-Care Diagnostics Market

• Market Trend: Advancements In Portable Point-Of-Care RT-PCR Solutions Help Enhancing Infectious Disease Diagnosis At The Point Of Care

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Primary Care POC Diagnostics Market?

A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor's office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation.

The main products of primary care POC diagnostics are glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, and others. Glucose monitoring refers to the process of measuring blood glucose levels to manage diabetes. These are based on prescription types such as prescription-based and over-the-counter (OTC) testing and used in various end uses, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

Primary Care POC Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Primary Care POC Diagnostics Market Size 2025 And Growth Rate?

The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $16.35 billion in 2024 to $17.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, shift towards personalized medicine, growing healthcare expenditure, rise in supportive regulatory frameworks and expedited approval processes, and growing emphasis on early disease detection and prevention strategies.

What Is The Primary Care POC Diagnostics Market Growth Forecast?

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the emergence of infectious disease outbreaks, expanding applications in non-communicable diseases, increasing adoption in home healthcare settings, growth in precision medicine initiatives, rising healthcare infrastructure investments, increasing disease burden, and growing awareness of the importance of early disease detection. Major trends in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, miniaturization and portability of POC diagnostic devices, integration of smart devices, and usage of multiplexing and panel testing in POC diagnostics.

The forecast of 7.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of rapid Point-of-Care diagnostics by inflating prices of lateral flow assays and biosensor components developed in Germany and Japan, resulting in delayed infection detection and higher outpatient testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Primary Care POC Diagnostics Market Segmented?

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: blood glucose meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, hemoglobin a1c testing devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

What Is Driving The Primary Care POC Diagnostics Market? Driving Forces Behind The Growth Of Primary Care Point-Of-Care Diagnostics Market

The rise in the prevalence of infectious diseases is expected to propel the growth of the primary care POC diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. These diseases spread from one person to another directly or indirectly through contact with contaminated surfaces, air, water, or vectors such as insects. The prevalence of infectious diseases is due to poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage. Primary care POC diagnostics are integral tools for combating the prevalence of infectious diseases by facilitating early detection, timely treatment, and effective disease control measures in diverse healthcare settings. For instance, in October 2023, according to a report published by the UK Health Security Agency, a UK-based government agency responsible for overseeing and managing public health security, the number of HIV diagnoses in England rose by 22% from 3,118 in 2021 to 3,805 in 2022. Furthermore, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, around 10.6 million cases of tuberculosis (TB) occurred globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the rise in the prevalence of infectious diseases is driving the primary care POC diagnostics industry.

Who Are The Major Players In The Global Primary Care POC Diagnostics Market?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

What Are The Key Trends Of The Global Primary Care POC Diagnostics Market? Advancements In Portable Point-Of-Care RT-PCR Solutions Help Enhancing Infectious Disease Diagnosis At The Point Of Care

Major companies operating in the primary care POC diagnostics market are focusing on technologically advanced solutions, such as portable point-of-care RT-PCR solutions, to maximize their revenue in the market. Portable point-of-care (POC) RT-PCR solutions are compact, mobile devices designed to perform real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratory settings. For instance, in October 2022, Genes2Me Pvt. Ltd., an India-based manufacturer of molecular diagnostic solutions, launched the Rapi-Q Point of Care RT PCR solution for diseases such as HPV and tuberculosis. This solution has an eight-well block design with four fluorescent channels, is claimed to be easy to use, and can provide faster results in less than 45 minutes. The Rapi-Q system is portable and lightweight, making IT suitable for hospitals, blood banks, health clinics, research laboratories, and airports. The solution offers high sensitivity, accuracy, and performance in detecting various diseases and is compatible with over 50 lyophilized, room-temperature disease detection kits.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Primary Care POC Diagnostics Market? Roche Expands Diagnostic Portfolio With Acquisition Of Lumiradx's Point-Of-Care Technology

In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, acquired LumiraDx's point-of-care technology form LumiraDx for 350 million. With this acquisition, Roche aims to expand its diagnostic portfolio and improve access to decentralized testing, particularly in primary care settings and low- to middle-income countries. LumiraDx is a UK-based, point-of-care diagnostic company that focuses on transforming community-based healthcare.

What Is The Regional Outlook For The Global Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Primary Care POC Diagnostics Market?

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Primary Care POC Diagnostics Industry?

The primary care poc diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the primary care poc diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Primary Care POC Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.38 billion
Revenue Forecast In 2034 $22.88 billion
Growth Rate CAGR of 7.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses Subsegments: 1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices 6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits 7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices 8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices 9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests 10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Primary Care POC Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Primary Care POC Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Primary Care POC Diagnostics Market Growth Rate Analysis

5.4. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Primary Care POC Diagnostics Total Addressable Market (TAM)

6. Primary Care POC Diagnostics Market Segmentation

6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Glucose Monitoring

Cardiometabolic Testing Products

Infectious Disease Testing Products

Coagulation Testing Products

Pregnancy And Fertility Testing Products

Tumor Or Cancer Marker Testing Products

Cholesterol Testing Products

Hematology Testing Products

Drug-Of-Abuse (DOA) Testing Products

Other Products

6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription Based

Over-The-Counter (OTC) Testing

6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Research Laboratories

Home-Care Settings

Other End-Uses

6.4. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Glucose Meters

Continuous Glucose Monitoring (Cgm) Systems

Test Strips For Glucose Meters

Glucose Control Solutions

6.5. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cardiometabolic Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Pressure Monitors

Lipid Profile Testing Kits

Hemoglobin A1c Testing Kits

Ecg Or Ecg Monitors

Hba1c Point-Of-Care Devices

6.6. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Infectious Disease Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rapid Strep Tests

Influenza (Flu) Testing Kits

Covid-19 Rapid Tests

Hiv Rapid Testing Kits

Hepatitis Testing Kits

Malaria Rapid Diagnostic Tests (Rdts)

Other Infectious Disease Tests

6.7. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Coagulation Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prothrombin Time (Pt) Testing Kits

International Normalized Ratio (Inr) Monitors

Activated Partial Thromboplastin Time (Aptt) Testing Kits

Coagulation Control Solutions

Whole Blood Coagulation Monitors

6.8. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Pregnancy And Fertility Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Home Pregnancy Tests (Urine-Based)

Ovulation Prediction Kits

Pregnancy Test Strips

Fertility Monitoring Devices

6.9. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Tumor Or Cancer Marker Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Psa (Prostate-specific Antigen) Testing Kits

Cea (Carcinoembryonic Antigen) Testing Kits

Ca-125 (Ovarian Cancer Marker) Kits

Her2 Testing Kits

Other Tumor Marker Test Kits

6.10. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cholesterol Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Total Cholesterol Testing Kits

Ldl Or Hdl Testing Kits

Triglyceride Testing Kits

Point-Of-Care Lipid Panel Devices

6.11. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Hematology Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hemoglobin Test Kits

Hematocrit Testing Kits

Complete Blood Count (Cbc) Kits

Point-Of-Care Hematology Analyzers

Hemoglobin A1c Testing Devices

6.12. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Drug-Of-Abuse (Doa) Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urine Drug Tests

Oral Fluid Drug Tests

Saliva-Based Drug Tests

Blood-Based Drug Tests

Breath Alcohol Tests

6.13. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergy Testing Kits

Urinalysis Test Strips

Vitamin And Mineral Deficiency Testing Kits

Point-Of-Care Liver Function Tests

Kidney Function Testing Products

Blood Gas Testing Devices

7. Primary Care POC Diagnostics Market Regional And Country Analysis

7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Primary Care POC Diagnostics Market

8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Primary Care POC Diagnostics Market

9.1. China Primary Care POC Diagnostics Market Overview

9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Primary Care POC Diagnostics Market

10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Primary Care POC Diagnostics Market

11.1. Japan Primary Care POC Diagnostics Market Overview

11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Primary Care POC Diagnostics Market

12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Primary Care POC Diagnostics Market

13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Primary Care POC Diagnostics Market

14.1. South Korea Primary Care POC Diagnostics Market Overview

14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Primary Care POC Diagnostics Market

15.1. Western Europe Primary Care POC Diagnostics Market Overview

15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Primary Care POC Diagnostics Market

16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Primary Care POC Diagnostics Market

17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Primary Care POC Diagnostics Market

18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Primary Care POC Diagnostics Market

19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Primary Care POC Diagnostics Market

20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Primary Care POC Diagnostics Market

21.1. Eastern Europe Primary Care POC Diagnostics Market Overview

21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Primary Care POC Diagnostics Market

22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Primary Care POC Diagnostics Market

23.1. North America Primary Care POC Diagnostics Market Overview

23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Primary Care POC Diagnostics Market

24.1. USA Primary Care POC Diagnostics Market Overview

24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Primary Care POC Diagnostics Market

25.1. Canada Primary Care POC Diagnostics Market Overview

25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Primary Care POC Diagnostics Market

26.1. South America Primary Care POC Diagnostics Market Overview

26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Primary Care POC Diagnostics Market

27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Primary Care POC Diagnostics Market

28.1. Middle East Primary Care POC Diagnostics Market Overview

28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Primary Care POC Diagnostics Market

29.1. Africa Primary Care POC Diagnostics Market Overview

29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles

30.1. Primary Care POC Diagnostics Market Competitive Landscape

30.2. Primary Care POC Diagnostics Market Company Profiles

30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Becton, Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

31. Primary Care POC Diagnostics Market Other Major And Innovative Companies

31.1. Quidel Corporation

31.2. Sysmex Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. Nova Biomedical Corporation

31.5. Randox Laboratories Ltd

31.6. Ortho Clinical Diagnostics

31.7. Nipro Corporation

31.8. OraSure Technologies

31.9. Meridian Bioscience Inc

31.10. DiaSorin SpA

31.11. Sekisui Diagnostics LLC

31.12. EKF Diagnostics Holdings plc

31.13. Trinity Biotech plc

31.14. Fujirebio Diagnostics Inc.

31.15. Immunodiagnostic Systems Holdings PLC

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

34. Recent Developments In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Primary Care POC Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Primary Care POC Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Primary Care POC Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cardiometabolic Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Infectious Disease Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Coagulation Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Pregnancy And Fertility Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Tumor Or Cancer Marker Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cholesterol Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Hematology Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Drug-Of-Abuse (Doa) Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Hoffmann-La Roche Ltd Financial Performance
  • Table 85: Abbott Laboratories Financial Performance
  • Table 86: Siemens Healthineers AG Financial Performance
  • Table 87: Becton, Dickinson And Company Financial Performance
  • Table 88: bioMerieux SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cardiometabolic Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Infectious Disease Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Coagulation Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Pregnancy And Fertility Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Tumor Or Cancer Marker Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cholesterol Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Hematology Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Drug-Of-Abuse (Doa) Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Hoffmann-La Roche Ltd Financial Performance
  • Figure 85: Abbott Laboratories Financial Performance
  • Figure 86: Siemens Healthineers AG Financial Performance
  • Figure 87: Becton, Dickinson And Company Financial Performance
  • Figure 88: bioMerieux SA Financial Performance

Frequently Asked Questions

A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor's office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation. For further insights on this market, request a sample here

The market major growth driver - Driving Forces Behind The Growth Of Primary Care Point-Of-Care Diagnostics Market. For further insights on this market, request a sample here

The primary care poc diagnostics market size has grown strongly in recent years. It will grow from $16.35 billion in 2024 to $17.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, shift towards personalized medicine, growing healthcare expenditure, rise in supportive regulatory frameworks and expedited approval processes, and growing emphasis on early disease detection and prevention strategies. The primary care poc diagnostics market size is expected to see strong growth in the next few years. It will grow to " $22.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the emergence of infectious disease outbreaks, expanding applications in non-communicable diseases, increasing adoption in home healthcare settings, growth in precision medicine initiatives, rising healthcare infrastructure investments, increasing disease burden, and growing awareness of the importance of early disease detection. Major trends in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, miniaturization and portability of POC diagnostic devices, integration of smart devices, and usage of multiplexing and panel testing in POC diagnostics. For further insights on this market, request a sample here

The primary care poc diagnosticsmarket covered in this report is segmented –
1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices For further insights on this market,
request a sample here

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc. . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Portable Point-Of-Care RT-PCR Solutions Help Enhancing Infectious Disease Diagnosis At The Point Of Care. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon